Irbesartan
ایربسارتان
❤️ Cardiovascular SystemAngiotensin receptor blocker
Market / country: 🇺🇸 USA
Avapro (US)
🧮 Dose calculator
Hypertension · Regimen source: FDA Irbesartan · 2.2
- • Max 300 mg. Volume depletion or dialysis: start 75 mg. FDA Irbesartan · 2.2FDA Irbesartan · 2.4
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to any component. FDA Irbesartan · 4
- ⚠️ Boxed warning: fetal toxicity — stop as soon as pregnancy is detected. FDA Irbesartan · Boxed Warning
Formulations
- 75 mg tablet — tablet 🇺🇸 USA FDA Irbesartan · 3
- 150 mg tablet — tablet 🇺🇸 USA FDA Irbesartan · 3
- 300 mg tablet — tablet 🇺🇸 USA FDA Irbesartan · 3
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Irbesartan · Boxed Warning
“WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. • When pregnancy is detected, discontinue irbesartan tablets as soon as possible.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Irbesartan · 8.2
“There are no available data on the presence of irbesartan in human milk, effects on milk production, or the breastfed infant.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Irbesartan · 8.4
“Irbesartan, in a study at a dose of up to 4.5 mg/kg/day, once daily, did not appear to lower blood pressure effectively in pediatric patients ages 6 to 16 years.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Irbesartan · 8.5
“Of 4925 subjects receiving irbesartan tablets in controlled clinical studies of hypertension, 911 (18.5%) were 65 years and over, while 150 (3.0%) were 75 years and over.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA202254
- DailyMed (FDA label)FDA Irbesartan
- MedlinePlus (NIH)Irbesartan
- WHO ATC/DDDC09CA04
- Darooyab (Iran)Irbesartan
🇮🇷 Registered in Iran Darooyab · G-1718/Irbesartan
Dosage forms with Iranian generic codes, per Darooyab.
- 07826 · IBESARTAN 150MG TAB · قرص ایبسارتان ۱۵۰ میلیگرم
- 09110 · IRBESARTAN 150MG TAB · قرص ایربسارتان ۱۵۰ میلیگرم
- 09111 · IRBESARTAN 300MG TAB · قرص ایربسارتان ۳۰۰ میلیگرم
- 09109 · IRBESARTAN 75MG TAB · قرص ایربسارتان ۷۵ میلیگرم
- 51986 · IRBESARTAN TABLET ORAL 300 mg · قرص ایربسارتان ۳۰۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Irbesartan · 3FDA Irbesartan · 2.2FDA Irbesartan · 2.4FDA Irbesartan · 2.3FDA Irbesartan · 8.4FDA Irbesartan · 4FDA Irbesartan · Boxed WarningFDA Irbesartan · 8.2FDA Irbesartan · 8.5FDA Irbesartan · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1718/Irbesartan
- Clinical review⚠ Unverified